Mannatech, Incorporated Insider Trading

MTEX

⊜ Compare

Last 12 months

Insiders bought 62K on the open market and sold nothing.

Net open-market

+62K

3 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

2 / 0

executives and directors

Last open-market buy

May 2026

May 20, 2026

Get an email when MTEX's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
May 20	Larry A Jobe Director	Bought	2,803	$4.12	12K	4.2%	Form 4
May 19	Larry A Jobe Director	Bought	5,000	$4.20	21K	8.0%	Form 4
May 19	Kevin Andrew Robbins Director	Bought	7,100	$4.17	30K	27%	Form 4

May 20
Larry A Jobe
Director · bought 2,803 at $4.12
12K
4.2% of stake
May 19
Larry A Jobe
Director · bought 5,000 at $4.20
21K
8.0% of stake
May 19
Kevin Andrew Robbins
Director · bought 7,100 at $4.17
30K
27% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch MTEX, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Medicinal Chemicals & Botanical Products · Pick stocks to compare with MTEX

CompareIntrinsic value

FTLFFitLife Brands, Inc.

$8.18+3.68%80

NAGENiagen Bioscience Inc.

$2.52+6.78%61

NAIINatural Alternatives International Inc.

$1.10+3.77%3

MRMDMariMed Inc.

$0.06+25.83%35

CRONCronos Group Inc.

$3.51+3.85%81

LEEEFLeef Brands Inc.

$0.17+9.74%30

BTMDBiote Corp.

$1.23+9.38%53

CWLXFC21 Investments Inc.

No recent price8

Spot a number that looks wrong? Check it in MTEX's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing MTEX

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.